Cost-effectiveness analysis of HLA-B*15:02 screening before treatment of epilepsy in Indonesia – PubMed
Calculation of the cost-effectiveness of lifetime epilepsy therapy in this study found that the initial screening strategy with the HLA-B*15:02 test was the most cost-effective.